Instituto de Salud Carlos III
Laboratorio de Referencia e Investigación en Parasitología
Dr David Carmena is a senior researcher based at the Parasitology Reference and Research Laboratory of the Spanish National Center for Microbiology since May 2013 when he was awarded a Miguel Servet Fellowship of the Health Institute Carlos III, Ministry of Economy and Competitiveness. Since 2018 David is a recipient of a Distinguished Researcher position at the same institution. David's research focuses on zoonotic diseases caused by protist (Cryptosporidium, Cyclospora, Cystoisospora, Giardia, Entamoeba, Dientamoeba, Balantioides), stramenopile (Blastocystis sp.), and microsporidia (Enterocytozoon, Encephalitozoon) pathogens, with a particular interest in those aspects related to the diagnosis, epidemiology, transmission dynamics, zoonotic potential, and pathogenesis by these agents, both from the human and animal health perspective. David received his Ph.D. in Parasitology from the University of the Basque Country (Spain) in 2001. He completed his first postdoc at the Department of Biological Sciences, Imperial College London, UK (2002-04) before joining the Medical Research Council Clinical Sciences Centre, Imperial College London, UK first as a Research Assistant (2005-2007) and later as a Research Associate (2007-13). At the MRC CSC David was involved in a number of research projects orientated to investigate the role of protein kinases in the regulation of different metabolic pathways.

Moderator of 1 Session

03. Parasites of domestic and wild animals

Presenter of 1 Presentation

03. Parasites of domestic and wild animals

MOLECULAR EPIDEMIOLOGY OF BLASTOCYSTIS IN WILD UNGULATES IN THE IBERIAN PENINSULA (ID 2036)

Session Type
03. Parasites of domestic and wild animals
Date
08/24/2022
Session Time
10:45 - 12:15
Room
Hall B4.M5+6
Lecture Time
11:57 - 12:15
Onsite or Pre-Recorded
Onsite

Abstract

Abstract Body

We determined the occurrence and genetic diversity of Blastocystis sp. in wild ungulates in the Iberian Peninsula including nationwide sample collections from Portugal (n = 222) and Spain (n = 1,058). Faecal samples from three wild ungulate species in Portugal (genera Capreolus, n = 38; Cervus, n = 79; and Sus, n = 105) and eight wild ungulate species in Spain (genera Ammotragus, n = 20; Capra, n = 89; Capreolus, n = 93; Cervus, n = 329; Dama, n = 96; Ovis, n = 10; Rupicapra, n = 62; and Sus, n = 359) were retrospectively investigated by PCR. Next generation amplicon sequencing (NGS) data was used to assess presence of Blastocystis and subtype diversity within a sample. Blastocystis sp. was identified in 37.4% (95% CI: 31.0–43.8%) of the Portuguese samples, with minimum and maximum rates detected in roe deer (31.6%) and red deer (40.5%), respectively. In Spain, 8.7% (95% CI: 7.1–10.4%) of the samples were Blastocystis-positive. Minimum and maximum rates were identified in Iberian wild goats (3.4%) and roe deer (12.9%), respectively. Thirteen Blastocystis subtypes (ST2, ST5, ST10, ST13, ST14, ST15, ST21, ST23, ST24, ST25, ST26, ST30, and ST31) were identified by NGS circulating in the wild ungulate populations in the Iberian Peninsula. The presence of zoonotic Blastocystis ST2 and ST5 in wild ungulates suggests that they could be reservoirs for human infection with this parasite. Blastocystis mixed subtype infections were frequent (42.3%, 74/175), with some animals harbouring up to 11 subtypes. Marked differences in Blastocystis subtype distribution according to host species were observed between countries. NGS was a powerful tool to discern underrepresented or mixed subtype infections that were undetectable or unreadable by Sanger sequencing.

Hide